Herskowitz Neil
SEC-identified person · CIK 1298246 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Journey Medical Corp DERM | Director | filed 2021–2026 |
| Mustang BIO, INC. MBIO | Director | filed 2017–2025 |
| Checkpoint Therapeutics, Inc. CKPT | Director | filed 2016–2025 |
| Avenue Therapeutics, INC. ATXI | Director | filed 2017–2024 |
| Olympic Cascade Financial Corp OLYD.OB | Director | filed 2016–2019 |
| Origo Acquisition Corp OACQ | Director | filed 2014–2016 |
| TG Therapeutics, INC. TGTXD | Director | filed 2006–2014 |
| Innovive Pharmaceuticals, Inc. NA | Director | filed 2006–2008 |
| Chelsea Therapeutics International, Ltd. CHTP.OB | Director | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.